Hypoxia-inducible factor-2 regulates vascular tumorigenesis in mice.

作者: E B Rankin , J Rha , T L Unger , C H Wu , H P Shutt

DOI: 10.1038/ONC.2008.160

关键词: Regulation of gene expressionEndocrinologyHypoxia-inducible factorsCarcinogenesisGene expression profilingVascular endothelial growth factorBiologyCancer researchAngiogenesisTranscription factorTumor suppressor geneInternal medicine

摘要: The von Hippel-Lindau tumor suppressor pVHL regulates the stability of hypoxia-inducible factors (HIF)-1 and -2, oxygen-sensitive basic helix-loop-helix transcription factors, which mediate hypoxic induction angiogenic growth such as vascular endothelial factor. Loss function results in constitutive activation HIF-1 HIF-2 is associated with development highly vascularized tumors multiple organs. We have used a conditional gene-targeting approach to investigate relative contributions VHL-associated tumorigenesis mouse model liver hemangiomas. Here we demonstrate genetically that inactivation HIF-2alpha suppressed hemangiomas gene expression hepatocytes predominantly regulated by not HIF-1. These findings suggest dominant HIF pathogenesis pharmacologic targeting may be an effective strategy for their treatment.

参考文章(21)
Eamonn R Maher, Steven C Clifford, Nancy Fernandes da Silva, Frances M Richards, Mark R Morris, Farida Latif, Malgorzata Zatyka, Kai-Uwe Eckardt, Michael S Wiesener, Richard S Houlston, Identification of Cyclin D1 and Other Novel Targets for the von Hippel-Lindau Tumor Suppressor Gene by Expression Array Analysis and Investigation of Cyclin D1 Genotype as a Modifier in von Hippel-Lindau Disease Cancer Research. ,vol. 62, pp. 3803- 3811 ,(2002)
Johanna M. M. Gijtenbeek, Sandra H. E. Boots-Sprenger, Barbara Franke, Pieter Wesseling, Judith W. M. Jeuken, Cyclin D1 genotype and expression in sporadic hemangioblastomas. Journal of Neuro-oncology. ,vol. 74, pp. 261- 266 ,(2005) , 10.1007/S11060-004-7326-Z
Raju R. Raval, Kah Weng Lau, Maxine G. B. Tran, Heidi M. Sowter, Stefano J. Mandriota, Ji-Liang Li, Christopher W. Pugh, Patrick H. Maxwell, Adrian L. Harris, Peter J. Ratcliffe, Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. Molecular and Cellular Biology. ,vol. 25, pp. 5675- 5686 ,(2005) , 10.1128/MCB.25.13.5675-5686.2005
Linda Holmquist-Mengelbier, Erik Fredlund, Tobias Löfstedt, Rosa Noguera, Samuel Navarro, Helén Nilsson, Alexander Pietras, Johan Vallon-Christersson, Åke Borg, Katarina Gradin, Lorenz Poellinger, Sven Påhlman, Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype. Cancer Cell. ,vol. 10, pp. 413- 423 ,(2006) , 10.1016/J.CCR.2006.08.026
Peter White, John E. Brestelli, Klaus H. Kaestner, Linda E. Greenbaum, Identification of transcriptional networks during liver regeneration. Journal of Biological Chemistry. ,vol. 280, pp. 3715- 3722 ,(2005) , 10.1074/JBC.M410844200
E B Rankin, A J Giaccia, The role of hypoxia-inducible factors in tumorigenesis. Cell Death & Differentiation. ,vol. 15, pp. 678- 685 ,(2008) , 10.1038/CDD.2008.21
M. Gruber, C.-J. Hu, R. S. Johnson, E. J. Brown, B. Keith, M. C. Simon, Acute postnatal ablation of Hif-2α results in anemia Proceedings of the National Academy of Sciences of the United States of America. ,vol. 104, pp. 2301- 2306 ,(2007) , 10.1073/PNAS.0608382104
F.P. McGrath, R.G. Gibney, D.C. Morris, D.A. Owen, S.R. Erb, Case report: multiple hepatic and pulmonary haemangioblastomas--a new manifestation of von Hippel-Lindau disease. Clinical Radiology. ,vol. 45, pp. 37- 39 ,(1992) , 10.1016/S0009-9260(05)81467-9